GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)
Clinical trial NCT03815825 · COMPLETED
Trial details
- NCT number
- NCT03815825
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-04
- Primary completion
- 2024-04-18
- Enrollment
- 332
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.